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Abstract Alanyl-peptide nucleic acid (alanyl-PNA)/
DNA chimeras are oligomers envisaged to be beneﬁcial in
efﬁcient DNA diagnostics based on an improved molecular
beacon concept. A synthesis of alanyl-PNA/DNA chimera
can be based on the solid phase assembly of the oligomer
with mixed oligonucleotide/peptide backbone under DNA
synthesis conditions, in which the nucleotides are intro-
duced as phosphoramidites, whereas the nucleo amino
acids make use of the acid labile monomethoxytrityl
(MMT) group for temporary protection of the a-amino
groups and acyl protecting groups for the exocyclic amino
functions of the nucleobases. In this work, we realized for
the ﬁrst time the synthesis of all four MMT/acyl-protected
nucleo alanines, achieved by deprotection/reprotection of
the newly synthesized Boc/acyl intermediates, useful
monomers for the obtainment of (alanyl-PNA)/DNA chi-
meras by conditions fully compatible with the standard
phosphoramidite DNA synthesis strategy.
Keywords Amino acids   DNA recognition  
Molecular beacon   Protecting groups
Introduction
The unambiguous and fast detection of oligonucleotide
sequences in vitro and in vivo is currently a major goal
especially since more and more diseases are linked to their
genetic origin. In 1996 Tyagi and Kramer introduced the
concept of a molecular beacon (Fig. 1a) (Tyagi and Kramer
1996; Tyagi et al. 1998) as one of many diagnostic methods
for DNA single strand sequence detection, as well as mis-
match identiﬁcation, known so far (Pfeifer 1996; Taylor
1997; Didenko 2002). The molecular beacon is a DNA
single strand composed of a loop region having a length of
around 20 nucleotides with a sequence complementary to
the target DNA and a stem region in which about ten ter-
minal nucleotides are paired in a double strand (Fig. 1a)
(Tan et al. 2000). On the 50-o r3 0-terminus, respectively, a
ﬂuorophore and a quencher are linked. Fluorescence is
quenched as long as the stem region is paired in a double
strand. Recognition of the target DNA by formation of a
rigid helical double strand leads to separation of the termini
which can easily be detected by ﬂuorescence. Besides the
genetic analysis (Kostrikis et al. 1998; Socher et al. 2008)
and detection of point mutations (Kranaster et al. 2008;
Ficht et al. 2004; Valis et al. 2005), the molecular beacon
concept is also useful in real-time PCR (Tyagi and Kramer
1996; Tyagi et al. 1998), RNA detection in living cells
(Matsuo 1998), and also in the identiﬁcation of protein–
DNA interactions (Li et al. 2000). The introduction of
single molecule detection for the interaction of a molecular
beacon with DNA leads to an increase in sensitivity from
about 10
-7 Mt o1 0
-11 to 10
-12 M (Knemeyer and Sauer
2000). Nevertheless, the sensitivity based on this detection
is limited due to the solvent accessibility of the ﬂuorophore.
In order to gain even higher sensitivity for DNA
detection, we propose to use an alanyl-peptide nucleic acid
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beacon keeping the DNA recognition loop (Fig. 1a).
Alanyl-PNA is an artiﬁcial oligomer that forms speciﬁc
and stable double strands based on nucleobase recognition
(Diederichsen 1996). The alanyl-PNA pairing system is
orthogonal to oligonucleotides with respect to double
strand formation and provides a possibility to hide the
ﬂuorophore from polar solvent (Diederichsen and Weic-
herding 1999;K u ¨sel et al. 2005).
An alanyl-PNA oligomer is based on a regular peptide
backbone composed of alanyl amino acids that carry
covalently linked nucleobases in b-position of the side
chain (Fig. 2) (Diederichsen 1997a, b). Oligomerization of
the nucleo amino acids allows for the formation of rigid
and well deﬁned double strands with linear topology based
on base pair recognition, stacking, and solvation. Base
pairs are stacking with a distance of about 3.5 A ˚ providing
a completely extended peptide backbone. Nevertheless,
intercalation can be made possible by creating oligomers
with a missing base pair by introduction of glycines in
opposite positions (Diederichsen 1997b). Evidence for a
non-polar environment within the base stack of alanyl-PNA
is derived from a stabilizing effect by incorporation of
aromatic amino acids in alanyl-PNA (Diederichsen and
Weicherding 1999). Shielding of the ﬂuorophore from the
water environment when intercalated within the alanyl-
PNA duplex should be a major advantage of the chimeric
alanyl-PNA/DNA molecular beacon. To ensure for a stoi-
chiometrically well deﬁned system, the ﬂuorophore will be
covalently linked to the peptide backbone. Guanine
nucleobases in the complementary alanyl-PNA strand will
function as quencher (Knemeyer and Sauer 2000).
Materials and methods
General Remarks
The solvents used in this work were of the highest grade
available. All reagents were of analytical grade and used
without further puriﬁcation. Optical rotations were deter-
mined with a Perkin-Elmer 241 polarimeter. IR spectra
were recorded with a Perkin-Elmer 1600 Series FT-IR
spectrometer using KBr pellets. NMR spectra were
recorded with a Varian INOVA-500 instrument or a
Varian Unity 300 instrument. Chemical shifts are refer-
enced to the residual solvent peaks of [D6]DMSO (
1H:
d = 2.49 ppm;
13C: d = 39.5 ppm). ESI-MS data were
measured with a LCQ Finnigan spectrometer. HRMS data
were determined with a Bruker APEX-Q IV 7T spec-
trometer. Chromatographic separations were performed
using silica gel 60 (0.040–0.063 mm, Merck). HPLC
analysis was performed using either a Beckman System
Gold or Pharmacia A ¨kta Basic using YMC-Pack ODS,
RP-C18 columns for analytical samples (250 mm 9
4.6 mm, 5 lm, 120 A ˚) with a linear gradient of A (0.1%
TFA in H2O) to B (MeCN/H2O, 9:1 ? 0.1% TFA). The
optical purity was determined by HPLC analysis of the
amino acid dimers obtained with N-Boc-L-Ala-OSu.
Analytical thin-layer chromatography was performed by
DNA
recognition
A
Quencher Fluorophore
Q F
DNA stem G
B
C N
N C
5’ 3’
Alanyl-PNA
stem
Fig. 1 a Concept of a molecular beacon as described by Tyagi and
Kramer (Tyagi and Kramer 1996; Tyagi et al. 1998); b Molecular
beacon composed of alanyl-PNA stem hiding the ﬂuorophore (F)
within the nucleobase stack and DNA recognition loop
DNA
DNA
Fig. 2 Linear alanyl-PNA
double strand: a ﬂuorophore can
be hidden within the nucleobase
stack covalently linked to an
alanyl side chain instead of a
nucleobase
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123using Merck silica gel 60 F254 precoated aluminum
plates and visualized with UV light (254 nm) or by
dyeing with ninhydrin (3% in ethanol).
(L)-Na-tert-Butoxycarbonyl-b-[N
6-(anisoyl)adenin-9-
yl]alanine (7)
DBU (1.17 g, 7.66 mmol) was added to a solution of
N
6-anisoyl-adenine 8 (3.10 g, 11.5 mmol) in DMSO
(40 ml). A solution of Boc-L-serine lactone 5 (1.43 g,
7.66 mmol) in DMSO (6 ml) was slowly added and stirred
for 72 h at room temperature. The reaction was terminated
by addition of AcOH (1.00 ml), the solvent removed, and
the resulting oil coevaporated with toluene. The residue
was dissolved in EtOAc and puriﬁed by ﬂash chromato-
graphy (4 cm 9 25 cm, EtOAc/MeOH/H2O/AcOH = 160:
28:12:1). Removal of the solvent, repeated coevaporation
with toluene, and freeze drying provided product 7 as
white solid (1.13 g, 32%). The identity of monomer 7
was conﬁrmed by comparison of the obtained
13CN M R
data to those published by Howarth and Wakelin (1997)
for adenine-containing N7 and N9-regioisomers. TLC Rf:
0.71 (CHCl3:MeOH:H2O:HOAc = 7:3:0.3:0.03); ee 92%
(HPLC: tR 30.5 min, 5–50% B in 45 min); a ½ 
20
D =? 16.3
(c 0.08, MeOH); IR (KBr): ~ m = 3,426, 2,926, 1,697, 1,608,
1,458 cm
-1;
1H NMR (300 MHz, [D6]DMSO, 35C)
d = 10.90 (s, br, 1H, CO2H), 8.63 (s, 1H, H-2), 8.26 (s, 1H,
H-8), 8.02 (d,
3JH,H = 8.7 Hz, 2H, Ar), 7.04 (d,
3JH,H =
8.7 Hz, 2H, Ar), 6.09 (m, 1H, Boc-NH), 4.77 (m, 1H, H-b),
4.47 (m, 1H, H-a), 4.08 (m, 1H, H-b), 3.84 (s, 3H, OCH3),
1.05–1.35 (m, 9H, Boc);
13C NMR (75 MHz, [D6]DMSO,
35C) d = 171.3, 164.9, 162.4, 154.6, 152.8, 150.9, 149.9,
144.8, 130.4, 125.8, 124.8, 113.6, 77.6, 55.4, 45.5, 28.0;
MS (ESI) m/z 455.8 [M - H]
-; HRMS (ESI): calcd. for
C21H25N6O6: 457.1830; found 457.1835 [M ? H]
?.
(L)-Na-tert-Butoxycarbonyl-b-[N
4-(4-tert-
butylbenzoyl)cytosin-1-yl]alanine (10)
DBU (1.83 g, 12.0 mmol) was added at room temperature
to a solution of (4-tert-butylbenzoyl)cytosine 9 (2.28 g,
8.41 mmol) in DMSO (72 ml). A solution of Boc-L-serine
lactone 5 (1.50 g, 8.01 mmol) in DMSO (18 ml) was added
dropwise. After stirring overnight at room temperature the
reaction was terminated by addition of AcOH (1.00 ml).
The solvent was removed. The resulting oil was coevapo-
rated with toluene before puriﬁcation by repeated ﬂash
chromatography (4 cm 9 22 cm, AcOEt/MeOH/H2O/
AcOH = 160:28:12:1). Removal of solvent was followed
by repeated coevaporation with toluene, and freeze drying
led to amino acid 10 (1.53 g, 42%). TLC Rf 0.60
(CHCl3:MeOH:H2O:AcOH = 7:3:0.3:0.03); ee 99%
(HPLC: tR 30.6 min, 5–75% B in 40 min); a ½ 
20
D =- 106.3
(c 0.09, MeOH); IR (KBr): ~ m = 3,410, 2,925, 1,682, 1,607,
1,455 cm
-1;
1H NMR (300 MHz, [D6]DMSO, 35C)
d = 10.95 (s, br, 1H, CO2H), 7.93 (m, 3H, Ar, H-6), 7.50 (d,
3JH,H = 8.7 Hz, 2H, Ar), 7.18 (d,
3JH,H = 7.1 Hz, 1H, H-5),
6.37(m,1H,Boc-NH),4.58(m,1H,H-b),4.16(m,1H,H-a),
3.55 (m, 1H, H-b), 1.20–1.40 (m, 18H, tBu, Boc);
13CN M R
(75 MHz, [D6]DMSO, 35C) d = 171.8, 167.0, 162.8,
155.6, 155.0, 150.4, 146.8, 130.5, 128.2, 125.1, 95.3, 78.0,
61.5,51.8,34.7,30.8,28.0;MS(ESI)m/z481.5[M ? Na]
?;
HRMS (ESI): calcd. for C23H31N4O6: 459.2238; found
459.2241 [M ? H]
?.
(L)-Na-tert-Butoxycarbonyl-b-[(N
2-isobutyryl)-guanin-
9-yl]-alanine (11)
DBU (2.23 g, 14.7 mmol) was added at room temperature
to a solution of (isobutyryl)guanine 12 (4.12 g, 17.4 mmol)
in DMSO (15 ml). A solution of Boc-L-serine lactone 5
(2.50 g, 13.4 mmol) in DMSO (10 ml) was slowly added
and stirred overnight at room temperature. The solvent was
removed and the residue puriﬁed by chromatography
(5 cm 9 38 cm, DCM/MeOH/EtOH = 6:3:1). The frac-
tions were collected, concentrated and investigated by
NMR. The fractions containing the desired product, iden-
tiﬁed by comparison of the obtained
13C NMR data with
those previously published for N9-regioisomer (Kova ´cs
and Schme ´l 2000; Rosenbohm et al. 2004), were combined
and the solvent evaporated to dryness. After removal of
the solvent product 11 (1.86 g, 31%) was obtained as a
white solid. TLC Rf 0.66 (CHCl3:MeOH:H2O:AcOH =
7:3:0.3:0.03); ee 96% (HPLC: tR 27.0 min, 10–50% B in
50 min); a ½ 
20
D =- 60.0 (c 0.1, MeOH); IR (KBr):
~ m = 3,425, 2,976, 1,682, 1,609, 1,565, 1,409 cm
-1;
1H
NMR (500 MHz, [D6]DMSO, 35C) d = 12.05 (s, br, 1H,
NH), 11.68 (s, br, 1H, CO2H), 7.78 (s, 1H, H-8), 7.16 (m,
1H, Boc-NH), 4.47 (m, 1H, H-b), 4.34 (m, 1H, H-a), 4.22
(m, 1H, H-b), 2.79 (sept.,
3JH,H = 6.8 Hz, 1H, iBu), 1.15–
1.36 (m, 9H, Boc), 1.11 (d,
3JH,H = 6.8 Hz, 6H, iBu);
13C
NMR (125 MHz, [D6]DMSO, 35C) d = 180.1, 171.1,
155.2, 154.8, 148.7, 147.8, 140.0, 119.9, 78.4, 53.1, 43.7,
34.6, 28.0, 18.8; MS (ESI) m/z 431.4 [M ? Na]
?; HRMS
(ESI): calcd. for C17H25N6O6: 409.1830; found 409.1829
[M ? H]
?.
(L)-Na-(4-Monomethoxytrityl)-b-[thymin-1-yl]alanine(1)
In TFA (2 ml) Boc-b-[thymine-1-yl]alanine 6 (103 mg,
329 lmol) was dissolved and stirred at room temperature
for 2 h. TFA was removed in vacuo and repeatedly co-
evaporated with toluene. After lyophilization from H2O the
residue was dissolved in DMF (40 ml). Triethylamine
(133 mg, 1.32 mmol) and 4-monomethoxytritylchloride
(102 mg, 329 lmol) in DMF (2 ml) were added dropwise.
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123After stirring at room temperature for 1 h the solvent was
removed and the remaining oil was extracted three times
with DCM/H2O (2:1, 200 ml). The organic phase was dried
over Na2SO4 and concentrated in vacuo. Diethyl ether
(3 ml) was added and the suspension stirred at -28C
for 1 h. After centrifugation at -10C and separation
from diethyl ether a white solid was obtained. This pro-
cedure was repeated to give the amino acid 1 (65.6 mg;
41%). TLC Rf 0.70 (DCM:MeOH:NEt3 = 4:1:0.05);
a ½ 
20
D =? 35.5 (c 0.07, CHCl3); IR (KBr): ~ m = 3,440,
1,697, 1,668, 1,509 cm
-1;
1H NMR (500 MHz,
[D6]DMSO, 35C) d = 11.30 (s, br, 1H, CO2H), 7.73
(s, 1H, H-6), 7.13–7.30 (m, 12H, MMT), 6.77 (d,
3JH,H = 9.0 Hz, 2H, MMT), 5.73 (s, 1H, NH), 3.87 (s, 1H,
H-b), 3.71 (s, 3H, MMT–OCH3), 3.57 (m, 1H, H-b), 3.42
(m, 1H, H-a), 1.83 (s, 3H, CH3);
13C NMR (125 MHz,
[D6]DMSO, 35C) d = 173.6, 164.3, 157.5, 150.9, 141.0,
146.2, 143.0, 137.4, 129.7, 128.1, 126.2, 113.0, 107.5,
69.6, 55.2, 54.9, 50.7, 11.8; MS (ESI) m/z 484.6 [M -
H]
-; HRMS (ESI): calcd. for C28H28N3O5: 486.2024;
found 486.2028 [M ? H]
?.
(L)-Na-(4-Monomethoxytrityl)-b-[N
6-(anisoyl)adenin-
9-yl]alanine (2)
In TFA (2 ml) Boc-b-[N
6-(anisoyl)adenine-9-yl]alanine 7
(100 mg, 219 lmol) was dissolved and stirred at room
temperature for 1 h. TFA was removed in vacuo and
repeatedly evaporated with toluene. After lyophilization
from H2O the residue was dissolved in DMF (25 ml).
Triethylamine (89.1 mg, 876 lmol) and 4-mono-
methoxtritylchloride (136 mg, 440 lmol) in DMF (4 ml)
were added, stirred overnight at room temperature, and
concentrated in vacuo. The obtained oil was extracted
Three times with DCM/H2O (2:1, 200 ml), the organic
phase was dried over Na2SO4, and the solvent removed.
Diethyl ether (3 ml) was added and the suspension stirred
at -28C for 1 h. Centrifugation at -10C and separation
from the diethyl ether phase yielded amino acid 2
(92.0 mg, 67%) after repeated extraction. TLC Rf 0.27
(AcOEt:MeOH = 7:3); a ½ 
20
D =? 28.3 (c 0.1, CHCl3); IR
(KBr): ~ m = 3,430, 2,928, 1,704, 1,608, 1,458 cm
-1;
1H
NMR (500 MHz, [D6]DMSO, 35C) d = 11.99 (s, br, 1H,
CO2H), 8.66 (s, 1H, H-2), 8.65 (s, 1H, H-8), 8.07 (d,
3JH,H = 8.8 Hz, 2H, Ar), 7.05–7.20 (m, 12 H, Ar, MMT),
6.98 (d,
3JH,H = 8.9 Hz, 2H, MMT), 6.66 (d,
3JH,H = 9.0 Hz, 2H, MMT), 4.40 (m, 1H, H-b), 4.31 (m,
1H, H-b), 3.85 (s, 3H, anis.-OCH3), 3.67 (s, 3H, MMT–
OCH3), 3.56 (m, 1H, H-a);
13C NMR (125 MHz,
[D6]DMSO, 35C) d = 173.5, 162.5, 157.5, 157.4, 150.3,
147.9, 145.9, 145.8, 139.8, 137.1, 130.5, 129.5, 128.0,
127.9, 127.6, 126.1, 125.3, 113.6, 112.9, 69.5, 55.9, 55.4,
54.8, 46.6; MS (ESI) m/z 627.3 [M - H]
-; HRMS (ESI):
calcd. for C36H33N6O5: 629.2507; found 629.2513
[M ? H]
?.
(L)-Na-(4-Monomethoxytrityl)-b-[N
4-(4-tert-
butylbenzoyl)cytosin-1-yl]alanine (3)
Boc-b-[N
4-(4-tert-butylbenzoyl)cytosine-1-yl]-alanine 10
(100 mg, 219 lmol) was dissolved in TFA (2 ml,
26.1 mmol) and stirred at room temperature for 2 h. TFA
was removed in vacuo and the mixture repeatedly evapo-
rated with toluene. After lyophilization from H2O, the
residue was dissolved in DMF (40 ml). Triethylamine
(88.3 mg, 876 lmol) and 4-monomethoxytritylchloride
(136 mg, 0.44 mmol) in DMF (4 ml) were added and
stirred at room temperature for 2 h. The solvent was
removed in vacuo and the remaining oil was extracted three
times with DCM/H2O (2:1, 200 ml). The organic phase
was dried over Na2SO4 and concentrated in vacuo. Diethyl
ether (3 ml) was added and the suspension was stirred at
-28C for 1 h. After centrifugation at -10C and sepa-
ration from diethyl ether a white solid was obtained. This
procedure was repeated yielding amino acid 3 (33.8 mg,
25%). TLC Rf 0.39 (AcOEt:MeOH = 4:1); a ½ 
20
D = –14.8
(c 0.12, CHCl3); IR (KBr): ~ m = 3,432, 2,960, 1,691, 1,659,
1,488 cm
-1;
1H NMR (500 MHz, [D6]DMSO, 35C)
d = 11.18 (s, br, 1H, CO2H), 8.39 (d,
3JH,H = 7.2 Hz, 1H,
H-6), 7.98 (d,
3JH,H = 8.4 Hz, 2H, Ar), 7.53 (d,
3JH,H = 8.4 Hz, 2H, Ar), 7.40 (m, 1H, H-5), 7.10–7.30 (m,
12H, MMT), 6.76 (d,
3JH,H = 8.9 Hz, 2H, MMT), 4.10
(m, 1H, H-b), 3.67–3.76 (m, 4H, H-b, MMT–OCH3), 3.66
(m, 1H, H-a), 1.30 (s, 9H, tBu);
13C NMR (125 MHz,
[D6]DMSO, 35C) d = 173.6, 158.2, 157.5, 155.7, 151.4,
146.2, 145.8, 137.4, 129.6, 129.3, 128.3, 128.1, 128.0,
127.7, 126.1, 125.2, 113.0, 95.2, 69.5, 54.9, 54.7, 52.8,
34.7, 30.8; MS (ESI) m/z 629.3 [M - H]
-; HRMS (ESI):
calcd. for C38H39N4O5: 631.2915; found 631.2923
[M ? H]
?.
(L)-Na-(4-Methoxyphenyldiphenylmethyl)-b-[N
2-
(isobutyryl)-guanin-9-yl]-alanine (4)
TFA (6 ml, 78.3 mmol) was added to a suspension of
Boc-b-[N
2-(isobutyryl)guanine-9-yl]alanine 11 (200 mg,
490 lmol) in DCM (12 ml) at 0C and the resulting
solution was stirred at room temperature for 2 h. The sol-
vent was removed in vacuo and the residue was dissolved
in DMF (60 ml). Triethylamine (737 mg, 7.35 mmol) and
4-monomethoxytritylchloride (141 mg, 455 lmol) dis-
solved in DMF (5 ml) were added and the mixture stirred
at room temperature for 1 h before the solvent was evap-
orated. The resulting oil was extracted ﬁve times with
DCM/H2O (1:1, 200 ml), the organic phase was dried over
Na2SO4 and the solvent removed. Diethyl ether (3 ml) was
1304 G. N. Roviello et al.
123added and the suspension was stirred at -28C for 1 h.
After centrifugation at -10 C and separation from diethyl
ether a white solid was obtained. This procedure was
repeated yielding amino acid 4 (87.3 mg, 31%). TLC Rf
0.58 (AcOEt:MeOH = 1:1); a ½ 
20
D =? 48.9 (c 0.1,
MeOH); IR (KBr): ~ m = 3,442, 2,930, 1,682, 1,607,
1,560 cm
-1;
1H NMR (300 MHz, [D6]DMSO, 35C)
d = 12.05 (s, br, 1H, CO2H), 11.53 (m, 1H, NH), 8.35
(s, 1H, H-8), 7.00–7.20 (m, 10H, MMT), 6.93 (d,
3JH,H = 9.0 Hz, 2H, MMT), 6.62 (d,
3JH,H = 9.1 Hz, 2H,
MMT), 4.41 (m, 1H, H-b), 4.29 (m, 1H, H-b), 3.66 (s, 3H,
OCH3), 3.56 (m, 1H, H-a), 2.76 (sept.,
3JH,H = 6.8 Hz, 1H,
iBu), 1.10–1.20 (m, 6H, iBu-CH3);
13C NMR (75 MHz,
CDCl3,3 5 C) d = 180.1, 172.2, 154.9,149.1, 147.8, 145.4,
145.5, 141.3, 136.9, 129.5, 127.9, 127.5, 126.2, 120.0,
112.8, 69.3, 56.0, 54.9, 45.8, 34.6, 18.9; MS (ESI) m/z
579.8 [M - H]
-; HRMS (ESI): calcd. for C32H33N6O5:
581.2507; found 581.2510 [M ? H]
?.
Determination of enantiomeric excess
The alanyl nucleo amino acids (5.00 lmol, 1.00 eq.) were
N-deprotected by TFA treatment. N-Boc-L-Ala-OSu
(8.68 mg, 30.0 lmol, 6.00 eq.) was dissolved in 350 ll
THF was added to the respective nucleo amino acid
dissolved in water (175 ll) and NaHCO3 buffer (175 ll,
pH 9, c = 1.2 mol/l). The mixture was kept for 5 h at
room temperature before it was brought to pH 2.5 by
addition of 10% TFA. The solid residue was ﬁltered and
5 ll of the solution was used for HPLC analysis on a RP
C18 column. The integration of the peak areas of both
dipeptide diastereomers at 254 nm provided the enantio-
meric excess.
Results and discussion
A molecular beacon composed of an alanyl-PNA stem and a
DNA recognition part requires the preparation of alanyl-
PNA/DNA/alanyl-PNA chimeras (Fig. 3a). They might be
obtained either by ligation of two alanyl-PNA fragments to
the 30- and 50-termini of the DNA single strand, respec-
tively, (Ede et al. 1994; Arar et al. 1995; Vives and Lebleu
1997; Harrison and Balasubramanian 1998; McMinn and
Greenberg 1999; Forget et al. 2001; Zatsepin et al. 2002;
Ollivier et al. 2002) or by solid phase synthesis of the whole
chimeric strand under DNA synthesis conditions (Berg-
mann and Bannwarth 1995; Truffert et al. 1996; Antopolsky
and Azhayev 1999, 2000; Sakakura and Hayakawa 2000;
Antopolsky et al. 2002; Stetsenko et al. 2002; Musumeci
et al. 2004). Uhlmann and van Boom already reported the
stepwise solid phase synthesis of aminoethylglycine-PNA/
DNA-chimera (Fig. 3b) (Uhlmann et al. 1998, 1999; Vin-
yak 1999; Van der Laan et al. 1995, 1997) adapting the
protecting group strategy for nucleo amino acids to DNA
synthesis conditions. The protection of the nucleo amino
acids needs to be compatible with the DNA phosphorami-
dite chemistry: the acid labile monomethoxytrityl (MMT)
protection and the acyl protecting groups on the exocyclic
amino functions of the nucleobases are suitable for this
purpose (Stetsenko et al. 1996; Breipohl et al. 1997).
Indeed, the MMT-protected monomers show good solu-
bility in the polar organic solvents (e.g. DMF) used for the
synthesis of the oligomers and the conditions for removing
the MMT protecting group (3% trichloroacetic acid) are
mild and do not cause depurination in the DNA portion of
the chimeras. Moreover, in the peptide synthesis by MMT-
chemistry every coupling can be monitored by measuring
the absorbance of the released MMT
? ion (e478 = 65,000).
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123In this work, the enantioselective synthesis of MMT-
protected nucleo amino acids 1–4 (Fig. 4) was provided
for the ﬁrst time by preparation of the four Boc-alanyl
nucleo amino acids followed by an exchange of the ter-
minal amino protecting group. Nevertheless, the need for
acyl protection of the nucleobases afforded a reinvesti-
gation of the Boc-amino acid synthesis with the respective
nucleobase, thus, leading to the synthesis of the new Boc/
acyl-protected nucleo amino acids (7, 10 and 11,
Scheme 1).
Synthesis of Boc-alanyl nucleo amino acids
Boc-protected alanyl nucleo amino acids are obtained by
ring opening of Boc-L-serine lactone (5) (Arnold et al.
1985) with the respective nucleobase (Scheme 1) (Lohse
et al. 1996; Diederichsen et al. 2005). Since thymine is the
only nucleobase that does not require protection, nucleo
amino acid 6 was obtained as described in literature (Lohse
et al. 1996). Na-Boc-b-[N
6-(Anisoyl)adenine-9-yl]alanine
(7) was provided in 32% yield by ring opening of Boc-L-
serine lactone 5 with N
6-anisoyl-adenine (8) in DMSO with
DBU as a base. As known already for the reaction with the
unprotected nucleobases, the yield of the serine lactone
ring opening with DNA bases is quite low (22% in case of
adenine) (Diederichsen et al. 2005) due to their low solu-
bility, regioselectivity problems (N7 vs. N9 alkylation and
SN2 vs. carbonyl attack on the serine lactone), polymeri-
zation of the serine lactone, and racemization. Neverthe-
less, despite extensive studies for improvement of this
reaction, up to date this route turned out to be most efﬁ-
cient. The enantiomeric purity was investigated for nucleo
amino acid 7 (92% ee) as well as for all other derivatives
described herein by Boc-deprotection followed by dipep-
tide formation with the Boc-L-Ala-OSu active ester and
HPLC analysis of the respective diastereomers. N
4-(4-tert-
Butylbenzoyl)cytosine (9) was also converted to the Na-
Boc-b-[N
4-(4-tert-butylbenzoyl)cytosine-1-yl]alanine (10)
in DMSO by the help of DBU with moderate yield (42%)
but excellent enantiomeric purity (99% ee). Regarding
synthesis of the (L)-Na-Boc-b-[N
2-(isobutyryl)guanin-9-
yl]alanine (11), N
2-(isobutyryl)guanine (12) was reacted
with Boc-L-serine lactone (5) in DMSO and with DBU as
base to yield the desired Boc-protected nucleo amino acid
with N9-substituted isobutyryl-guanine 11 in a mixture
with the N7 regioisomer (L)-Na-Boc-b-[N
2-(isobuty-
ryl)guanin-7-yl]alanine. Subsequently, the mixture of N9
and N7 nucleo amino acids was separated by silica gel ﬂash
chromatography. The fractions containing the desired
product, identiﬁed by comparison of the obtained
13CN M R
data with those previously published for guanine-contain-
ing N9-regioisomers (Kova ´cs and Schme ´l 2000; Rosenb-
ohm et al. 2004), were combined and the solvent
evaporated to dryness. In this way Na-Boc-b-[N
2-(isobu-
tyryl)guanin-9-yl]alanine (11) was provided in 31% yield
with an optical purity of 96% ee.
Synthesis of MMT-protected nucleo amino acids
The usual procedures for N-terminal MMT protection of
amino acids (Mamos et al. 1988; Canle et al. 2000) require
workup under basic conditions, which would lead to acyl
deprotection in case of the nucleo amino acids. MMT-
protected nucleo amino acids 1–4 were obtained starting
from the respective Boc-derivatives 6, 7, 10 and 11 by Boc-
deprotection with TFA and immediate tritylation of the free
nucleo amino acids with monomethoxytrityl chloride in
DMF in presence of triethylamine (Scheme 1). The desired
protected monomers were directly obtained by precipita-
tion from diethyl ether at -28C. This straightforward
route was chosen even because silica gel chromatography
of the MMT-amino acids using acidic eluents for
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123protonation of the carboxylate moiety causes the depro-
tection of the acid labile trityl protection.
Conclusion
The enantioselective preparation of all canonical alanyl
nucleo amino acids with MMT-protected a-amino groups
and acyl-protected exocyclic amino functions of the
nucleobases was presented for the ﬁrst time in this work. It
was made possible by the synthesis of the respective N-Boc
nucleo amino acids, carried out by adapting the synthetic
routes to the Boc-protected alanyl amino acids in the case
of the acyl-protected nucleobases, and, after Boc removal,
their reprotection by the MMT group. These novel deriv-
atives will be advantageous in the solid phase synthesis of
alanyl-PNA/DNA chimeras, by conditions fully compatible
with the standard phosphoramidite DNA synthesis strategy,
which might serve as a tool for very sensitive DNA
detection following the molecular beacon concept.
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